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1. Introduction1
Venous thromboembolism (VTE) is a clinical common 
disease, frequently-occurring disease, which include lower 
extremity deep vein thrombosis (DVT) and pulmonary 
embolism (PE). VTE patients experienced a fatal PE after 
termination of anticoagulant probability is 0.19%−0.49%. 
With the increase of economic development, obesity and 
an aging population, activity decreases, the extension of 
time in bed, and tumors, the incidence of chronic diseases 
such as COPD increases year by year, However, as the fur-
ther recognition of VTE, hemal wall damage, stagnation of 
blood flow, blood high condensation state is acknowledged 
as the venous thrombosis of the three factors [1,3,10]. The 
three often exist at the same time, restrict each other. Lead 
to many risk factors for venous thrombosis thus Increase 
the risk factors for deep vein thrombosis of knowledge and 
understanding. This will help to improve the clinical diag-
nosis and reduce the complications and reduce mortality.
2. Sex and age
Research shows that the incidence rate of VTE in women is 
lower than men before the age of 50, which may be related 
to the level of estrogen in women. Martinelli et al. found 
that the recurrence rate of VTE was higher in female than 
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male. Studies have indicated that the incidence of venous 
thromboembolism in women with upper extremity venous 
thrombosis can be increased by 9 times [2].
The incidence of DVT and PE are increased, which may 
be due to the increase in age and other diseases. Other 
diseases are may be the real risk factors of PE and DVT. 
However, another study of age and VTE recurrence rates 
showed that the recurrence rate of VTE was not correlated 
with the age of onset of VTE in patients [4−7].
3. Living habits
Limb activity decreased, long-term bed, limb fixation, 
postural movements (long-distance travel, by plane, etc.), 
can lead to lower limb muscle massage action disap-
peared, venous blood flow driving force. A case control 
study on the risk factors of VTE occurrence in a long-
term sedentary population at work. The correlation coef-
ficient between sedentary population and VTE was 1.8. A 
positive correlation between the time and the incidence 
of VTE was 10%. With prolonged sitting time to a certain 
extent with every l hour, the incidence rate of VTE will 
increase by 20% [8].
4. Weight
Currently thinking, obesity is not independent VTE risk 
factors. The menopausal women’s body mass index greater 
than 30 where the DVT risk increased significantly. The 
postoperative DVT occurrence rate can be increased 2 
times. The reason is that obese people reduce the volume 
of activities, slow blood flow; right heart pressure too high 
can lead to blood descent propulsion. It is easy to cause 
stagnant blood flow and thrombosis as reported by Guan 
Zhenpeng et al. [9]. Obesity is an important risk factor for 
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5. Pregnancy or postpartum
Thromboembolic disease has become one of the important 
causes of death in pregnant women. From the physiologi-
cal and anatomical factors, the venous reflux obstruction 
and blood stasis in the pregnant women can lead to vas-
cular endothelial cell damage, thus lead to thrombosis. In 
addition, because of the way of the left lower extremity 
venous return to the inferior vena cava, the right common 
iliac artery oppression left iliac vein and so on.
Pregnant women in the blood fibrinogen where coagu-
lation factors are factor II, VII, VIII and X. Reduced fi-
brinolytic activity will decreased free protein S levels, and 
anti-protein C activity enhancement, so that the blood of 
pregnant women is in hypercoagulable state. Myometrial 
and placental decidua which contain rich thromboplastin 
at birth trauma and birth injury, can make the these active 
substance release a lot thus increased clotting tendency, 
resulting in a further increase in the risk of thrombosis. 
Second, age is more than 35 years old, obesity, smoking, 
prolific, postpartum hemorrhage and blood transfusion, 
pregnancy induced hypertension, excessive increase of the 
uterus (amniotic fluid, combined with uterine fibroids), 
cesarean section (especially emergency cesarean section), 
long-term immobilization, cardiac insufficiency, lower ex-
tremity varicose and chronic hypertension and other risk 
factors of VTE [11−16].
6. Tumors
Thrombosis is one of the serious complications of ma-
lignant tumor, and it is also the cause of death in second 
patients. The occurrence rate was 5 to 6 times higher than 
that of non-malignant tumor patients in the general popu-
lation. Tumor associated thrombosis was Trousseau syn-
drome. The syndrome includes DVT, pulmonary throm-
boembolism, dispersion of intravascular coagulation, 
portal vein thrombosis and arterial thromboembolism, 
walk superficial thrombophlebitis etc., of which the fol-
lowing limb DVT is most common. Studies have indicated 
that the most closely related risk factors for tumor patients 
and thrombosis include tumor type, stage (early stage), 
location (brain, lung, ovary, pancreas, colon), anti-tumor 
therapy (chemotherapy, hormone, anti VEGF agents, sur-
gery), other risk factors (brake, VTE family history, past 
VTE History), coagulation factor Leiden (V 20210A, pro-
thrombin mutation).
7. Surgery and trauma
Surgery and fractures are common risk factors for PE. Af-
ter surgery, the causes of VTE were vascular endothelial 
injury, long-term immobilization and surgical trauma, etc.. 
In the operation, the blood volume are insufficient and the 
tissue factor is released into the blood, which can lead to 
high blood coagulation state and certain surgical specific 
requirements to DVT incidence of increased significantly 
such as laparoscopic surgery. Reversed Trendelenburg po-
sition to increase the resistance of blood flow in the veins, 
hip joint and knee joint by using tourniquet limb. It will 
impede the venous return and caused blood stasis. At the 
same time, the operation time, anesthesia time, anesthe-
sia methods are also related to the incidence of VTE. Li 
Guanghui et al. [17] showed that the incidence of DVT in 
patients receiving epidural anesthesia was 9.5%, and the 
incidence of DVT was 26.2%.
8. Serious department of internal medicine disease
In the past, hyperlipidemia, hypertension, diabetes, coro-
nary heart disease and other diseases related to arterial 
thrombosis. It has been confirmed that there is a close 
connection between the venous thrombosis and the risk 
factors of venous thrombosis. Chronic cardiopulmonary 
cerebral vascular disease is one of the main risk factors of 
PE. Respiratory tract infections were closely associated 
with VTE. In addition, in Matta [18] research results also 
indicate that the rheumatoid arthritis patients with PE and 
DVT incidence rate were higher than those in non-rheu-
matoid arthritis patient, suggest rheumatoid arthritis is a 
VTE risk factors. Reported in the literature and anticardio-
lipin antibody positive patients and systematic lupus ery-
thematosus patients with VTE occurrence rate of 47.57% 
(49/103) and 25.6% (11/43) respectively. Laboratory index-
es in lupus anticoagulant antibody levels were significantly 
elevated. Protein S and C content decreased significantly. 
Anticardiolipin antibodies of IgG and IgM were positive 
for DVT were proportion higher. The relationship between 
human immunodeficiency virus (HIV) and VTE has also 
been reported. A survey showed that the incidence of PE 
infection in patients with HIV was 0.4%, and the incidence 
of DVT was 1.4%, which was higher than that of patients 
without HIV infection.
9. Iatrogenic factors
With the development of various new clinical diagnoses, 
treatment technology and the wide application of new 
drugs, some of the VTE caused by iatrogenic factors has 
gradually attracted the attention of the clinician. Incidence 
rate is 3−10% and VTE in general within 6 months after the 
start of treatment with thalidomide occurred. They specu-
lated that the bolt mechanism may be through effects on 
vascular endothelial cell function and anticoagulation and 
fibrinolysis soluble activity and increased risk dish liquid of 
tumor thrombosis in patients with multiple myeloma tumor 
patients with VTE. In addition, there were some studies 
showing that the risk of VTE in patients with sedative and 
antipsychotic drugs was significantly increased [19]. In ad-
dition, in the deep venous set tube using the most common 
oncology and critical diseases in patients with upper ex-
tremity DVT where the proportion of a gradual is increased.
10. Primary prevention
Hospitalized patients are often faced with a variety of 
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VTE risk factors. These risk factors have cumulative effect. 
Therefore, the VTE risk assessment should be carried out 
at the time of admission. Researchers at the University of 
Massachuselrs, who reviewed 1464 patients, evaluated the 
possibility of DVT by using an impedance analyzer. The re-
sults showed that only 11% of the patients with DVT were 
clinically suspected of high risk factors. The incidence of 
VTE increased with the increase of risk factors, and when 
there were 3 high risk factors, it can be increased to 50%. 
Scholars at local and international have tried to evaluate 
and monitor the VTE high risk population in the presence 
of multiple risk factors, which is helpful for early detection 
and timely diagnosis and treatment. The primary preven-
tion of venous thromboembolism is the prevention of risk 
factors, which can cause blood to high blood coagulation 
state, blood stasis and endothelial injury. Basic disease 
treatment is the first such as the cause cannot be removed 
to take drugs, etc. [20,21]. There are 3 ways to prevent ve-
nous thromboembolism: general prevention, preventive 
anti-coagulation, and mechanical methods. General pre-
ventive measures include appropriate fluid infusion, early 
bed and lower limb, active and passive activities of the 
lower limb, which is suitable for almost all hospital popu-
lation. Mechanical preventive measures include the appli-
cation of gradient pressure elastic stockings, intermittent 
pneumatic compression pumps and venous pump. Preven-
tive anticoagulation and mechanical methods are appli-
cable to the patients with indications, and the mechanical 
method is especially suitable for the prevention of the high 
risk of venous thromboembolism, which should be con-
sidered in combination with prophylactic anticoagulation 
and mechanical method [22]. In addition, some of the risk 
factors are to be removed, such as bed, respiratory failure, 
heart failure, etc. The removal of risk factors is one of the 
focus of prevention of venous thromboembolism.
In conclusion, the risk factors and pathogenesis of ve-
nous thrombosis were further recognized and understood. 
The prevention and treatment of VTE multiple risk factors 
in patients with high risk patients were improved.
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